拱东医疗收盘下跌1.45%，滚动市盈率23.80倍，总市值38.62亿元

Core Insights - The company, Gongdong Medical, closed at 24.51 yuan, down 1.45%, with a rolling PE ratio of 23.80 times and a total market capitalization of 3.862 billion yuan [1] - The average PE ratio in the medical device industry is 44.77 times, with a median of 29.66 times, placing Gongdong Medical at the 59th position in the industry ranking [1] - As of the Q3 2024 report, 67 institutions hold shares in Gongdong Medical, with a total of 8.8357 million shares valued at 248 million yuan [1] Company Overview - Gongdong Medical specializes in the research, production, and sales of disposable medical consumables [1] - The main product categories include vacuum blood collection systems, laboratory testing consumables, bodily fluid collection consumables, medical care consumables, and pharmaceutical packaging materials [1] - The products are widely used in clinical diagnosis and care, scientific research testing, and pharmaceutical packaging [1] - The company has obtained ISO13485 quality management system certification and has 29 domestic medical device registrations or filings [1] - Some products have also received FDA510(k) product approval and EU CE certification, ensuring stable and reliable quality during mass production [1] Financial Performance - For Q3 2024, Gongdong Medical reported revenue of 836 million yuan, a year-on-year increase of 17.31% [2] - The net profit for the same period was 141 million yuan, reflecting a year-on-year growth of 60.22% [2] - The sales gross margin stood at 33.35% [2]